The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-4,5-dihydro-2-[3-hydroxy-4-(3,6-dioxaheptyloxy)-2-pyridinyl]-4-methyl-4-thiazolecarboxylic acid monosodium salt ID: ALA2163729
Chembl Id: CHEMBL2163729
PubChem CID: 136226893
Max Phase: Preclinical
Molecular Formula: C15H19N2NaO6S
Molecular Weight: 356.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COCCOCCOc1ccnc(C2=N[C@@](C)(C(=O)[O-])CS2)c1O.[Na+]
Standard InChI: InChI=1S/C15H20N2O6S.Na/c1-15(14(19)20)9-24-13(17-15)11-12(18)10(3-4-16-11)23-8-7-22-6-5-21-2;/h3-4,18H,5-9H2,1-2H3,(H,19,20);/q;+1/p-1/t15-;/m1./s1
Standard InChI Key: JVSAGTVZUPXSIV-XFULWGLBSA-M
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 356.40Molecular Weight (Monoisotopic): 356.1042AlogP: 1.17#Rotatable Bonds: 9Polar Surface Area: 110.47Molecular Species: ZWITTERIONHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.85CX Basic pKa: 10.89CX LogP: 0.04CX LogD: -0.72Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.63Np Likeness Score: -0.09
References 1. Bergeron RJ, Wiegand J, Bharti N, McManis JS.. (2012) Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles., 55 (16): [PMID:22889170 ] [10.1021/jm300509y ]